Immunogenicity and Safety of Co-immunization With Cecolin and Hecolin

Clinical trial NCT05415345 · UNKNOWN

Trial details

NCT number: NCT05415345
Sponsor: Xiamen Innovax Biotech Co., Ltd
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Human Papilloma Virus Infection Type 16 Human Papilloma Virus Infection Type 18 Hepatitis E Virus Infection

Start date: 2021-10-25
Primary completion: 2022-11-30
Enrollment: 480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.